| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
42,623 |
36,413 |
$6.02M |
| 99199 |
Unlisted special service, procedure or report |
21,074 |
17,621 |
$1.52M |
| 80053 |
Comprehensive metabolic panel |
42,503 |
36,993 |
$919K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
27,192 |
8,074 |
$790K |
| 0510 |
|
18,105 |
15,924 |
$730K |
| 97139 |
|
15,198 |
3,061 |
$436K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,290 |
6,993 |
$405K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,333 |
6,647 |
$402K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,160 |
10,072 |
$389K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,898 |
13,887 |
$382K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,458 |
2,449 |
$360K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,569 |
1,994 |
$344K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,409 |
3,408 |
$325K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,177 |
5,483 |
$267K |
| 97750 |
|
3,975 |
2,848 |
$257K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,505 |
8,760 |
$251K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,384 |
3,067 |
$241K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
4,785 |
2,487 |
$234K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,264 |
5,025 |
$227K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,918 |
3,763 |
$221K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
698 |
696 |
$210K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
46,180 |
40,110 |
$197K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,254 |
8,607 |
$192K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,991 |
3,883 |
$192K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,784 |
12,548 |
$187K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,815 |
6,767 |
$168K |
| 0760 |
|
3,893 |
3,315 |
$160K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,973 |
7,372 |
$155K |
| G0378 |
Hospital observation service, per hour |
4,074 |
3,618 |
$151K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,044 |
1,993 |
$141K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,354 |
2,217 |
$140K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,595 |
4,210 |
$136K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,123 |
6,151 |
$136K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,377 |
5,886 |
$133K |
| J3490 |
Unclassified drugs |
5,082 |
3,387 |
$126K |
| 80061 |
Lipid panel |
9,947 |
9,862 |
$115K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,051 |
3,853 |
$112K |
| 81001 |
|
24,486 |
21,579 |
$111K |
| 71046 |
Radiologic examination, chest; 2 views |
7,224 |
6,987 |
$106K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
92 |
92 |
$101K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,567 |
1,464 |
$99K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,359 |
2,302 |
$97K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,213 |
3,114 |
$94K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,824 |
3,636 |
$94K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,266 |
3,635 |
$92K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,894 |
7,417 |
$91K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,588 |
1,494 |
$91K |
| 76830 |
Ultrasound, transvaginal |
2,104 |
2,057 |
$88K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
995 |
945 |
$88K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,983 |
8,907 |
$88K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,057 |
2,988 |
$87K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,859 |
1,243 |
$86K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,649 |
12,000 |
$86K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,041 |
3,891 |
$84K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,057 |
2,989 |
$77K |
| 73630 |
|
2,412 |
2,249 |
$75K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,961 |
1,910 |
$72K |
| 73562 |
|
2,454 |
2,270 |
$68K |
| 73610 |
|
2,205 |
2,060 |
$67K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,113 |
1,251 |
$64K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,175 |
2,121 |
$63K |
| 97597 |
|
2,726 |
1,660 |
$62K |
| 0360 |
|
330 |
307 |
$62K |
| 73030 |
|
2,196 |
2,040 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,751 |
4,379 |
$61K |
| 0250 |
|
9,204 |
4,826 |
$57K |
| 73110 |
|
1,891 |
1,713 |
$55K |
| 84484 |
|
10,319 |
8,287 |
$55K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,499 |
3,416 |
$55K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
104 |
104 |
$55K |
| 82962 |
|
1,643 |
1,410 |
$54K |
| 73130 |
|
1,712 |
1,579 |
$54K |
| 97799 |
|
2,125 |
493 |
$53K |
| 72100 |
|
1,927 |
1,914 |
$52K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
986 |
914 |
$52K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,024 |
2,883 |
$51K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
584 |
525 |
$51K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
458 |
457 |
$50K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,150 |
1,102 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
469 |
449 |
$46K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,714 |
2,693 |
$45K |
| 84439 |
|
5,229 |
5,155 |
$45K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,733 |
1,732 |
$42K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
131 |
126 |
$41K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
569 |
568 |
$40K |
| 73502 |
|
1,122 |
1,111 |
$39K |
| 96367 |
|
889 |
500 |
$38K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
806 |
716 |
$37K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,393 |
2,113 |
$37K |
| 84145 |
|
946 |
922 |
$36K |
| 72141 |
|
119 |
119 |
$36K |
| 93971 |
|
889 |
868 |
$34K |
| 76770 |
|
716 |
710 |
$34K |
| J2060 |
Injection, lorazepam, 2 mg |
2,180 |
1,621 |
$34K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,162 |
1,756 |
$33K |
| 0270 |
|
8,980 |
4,904 |
$33K |
| 99070 |
|
12,798 |
6,769 |
$31K |
| 82728 |
|
3,222 |
3,161 |
$31K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
275 |
112 |
$31K |
| Z7500 |
|
885 |
856 |
$30K |
| 59025 |
Fetal non-stress test |
575 |
259 |
$30K |
| 82607 |
|
3,355 |
3,337 |
$30K |
| 83690 |
|
8,860 |
7,995 |
$29K |
| 81025 |
|
7,074 |
6,682 |
$28K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
6,561 |
5,923 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
547 |
545 |
$27K |
| 83735 |
|
6,494 |
5,364 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
903 |
879 |
$26K |
| 87400 |
|
1,693 |
1,580 |
$26K |
| 83880 |
|
4,523 |
4,208 |
$26K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
756 |
742 |
$25K |
| 84481 |
|
1,769 |
1,757 |
$25K |
| 76801 |
|
655 |
601 |
$25K |
| 84153 |
|
1,335 |
1,317 |
$25K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,663 |
6,458 |
$24K |
| 84466 |
|
2,033 |
2,004 |
$23K |
| 80143 |
|
1,248 |
1,121 |
$23K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
822 |
536 |
$23K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,007 |
994 |
$23K |
| 72050 |
|
517 |
514 |
$22K |
| 86140 |
|
5,660 |
5,313 |
$22K |
| 86803 |
|
1,368 |
1,356 |
$22K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
770 |
759 |
$21K |
| J2704 |
Injection, propofol, 10 mg |
591 |
556 |
$20K |
| 94060 |
|
659 |
496 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
6,052 |
5,688 |
$20K |
| 82746 |
|
1,157 |
1,149 |
$20K |
| 85610 |
|
10,094 |
8,883 |
$19K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,122 |
1,074 |
$19K |
| 93017 |
|
367 |
363 |
$18K |
| 83655 |
|
1,169 |
1,148 |
$18K |
| 90714 |
|
811 |
803 |
$18K |
| Z7502 |
|
494 |
485 |
$18K |
| 80074 |
|
317 |
316 |
$17K |
| 73140 |
|
632 |
582 |
$17K |
| 73221 |
|
65 |
62 |
$17K |
| 94729 |
|
653 |
470 |
$17K |
| 86901 |
|
1,127 |
1,029 |
$16K |
| 87081 |
|
3,482 |
3,409 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,448 |
2,130 |
$16K |
| 80055 |
|
327 |
326 |
$16K |
| 85027 |
|
3,056 |
2,834 |
$16K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
687 |
679 |
$16K |
| 83540 |
|
2,677 |
2,636 |
$16K |
| 76642 |
|
311 |
306 |
$16K |
| 94726 |
|
636 |
468 |
$16K |
| 86900 |
|
1,070 |
984 |
$16K |
| 84403 |
|
641 |
624 |
$15K |
| 80305 |
|
1,148 |
1,079 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
1,187 |
1,101 |
$15K |
| 87806 |
|
510 |
503 |
$14K |
| 87186 |
|
2,800 |
2,692 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
725 |
412 |
$13K |
| 97016 |
|
774 |
249 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
653 |
628 |
$12K |
| 11043 |
|
149 |
94 |
$12K |
| 97010 |
|
243 |
108 |
$12K |
| 83605 |
|
5,327 |
4,621 |
$12K |
| 84703 |
|
2,159 |
2,084 |
$12K |
| 86038 |
|
1,051 |
1,036 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,080 |
2,978 |
$12K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
136 |
110 |
$11K |
| 73080 |
|
352 |
327 |
$11K |
| 76536 |
|
209 |
205 |
$11K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
171 |
152 |
$11K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
322 |
185 |
$11K |
| 86592 |
|
1,519 |
1,476 |
$10K |
| 84702 |
|
660 |
545 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,051 |
1,801 |
$10K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,118 |
671 |
$10K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
51 |
49 |
$10K |
| 74018 |
|
579 |
549 |
$10K |
| 82948 |
|
1,046 |
855 |
$10K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
40 |
40 |
$10K |
| 85018 |
|
3,343 |
3,306 |
$10K |
| 87077 |
|
2,042 |
1,960 |
$9K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
547 |
479 |
$9K |
| 81003 |
|
2,469 |
2,391 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
129 |
120 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
650 |
602 |
$8K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
718 |
658 |
$8K |
| 82043 |
|
1,368 |
1,361 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,205 |
1,868 |
$8K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
718 |
495 |
$7K |
| 87040 |
|
3,613 |
2,458 |
$7K |
| 85652 |
|
3,292 |
3,130 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
37 |
37 |
$7K |
| 93016 |
|
239 |
236 |
$7K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
50 |
49 |
$6K |
| 85730 |
|
2,679 |
2,586 |
$6K |
| 72072 |
|
198 |
198 |
$6K |
| S0028 |
Injection, famotidine, 20 mg |
77 |
74 |
$6K |
| 82570 |
|
1,345 |
1,269 |
$6K |
| 86787 |
|
436 |
351 |
$6K |
| 80076 |
|
712 |
696 |
$5K |
| 93018 |
|
239 |
236 |
$5K |
| 87340 |
|
420 |
416 |
$5K |
| 85379 |
|
1,559 |
1,512 |
$5K |
| 83516 |
|
480 |
374 |
$4K |
| 71271 |
|
54 |
54 |
$4K |
| 86850 |
|
342 |
318 |
$4K |
| 87070 |
|
417 |
394 |
$4K |
| 73564 |
|
123 |
120 |
$4K |
| 97162 |
|
845 |
844 |
$4K |
| 86317 |
|
247 |
247 |
$4K |
| 93000 |
|
1,162 |
996 |
$4K |
| 85007 |
|
1,721 |
1,503 |
$3K |
| 82950 |
|
589 |
585 |
$3K |
| 0729 |
|
90 |
72 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
296 |
250 |
$3K |
| 93880 |
|
27 |
27 |
$3K |
| 73590 |
|
122 |
111 |
$3K |
| 93922 |
|
127 |
120 |
$3K |
| 81002 |
|
1,049 |
1,010 |
$3K |
| 62323 |
|
36 |
26 |
$3K |
| 82784 |
|
337 |
325 |
$3K |
| 71250 |
|
29 |
28 |
$2K |
| 80179 |
|
1,212 |
1,102 |
$2K |
| 86376 |
|
222 |
222 |
$2K |
| 83970 |
|
66 |
66 |
$2K |
| 76857 |
|
311 |
303 |
$2K |
| 70496 |
|
114 |
114 |
$2K |
| 0259 |
|
212 |
144 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
484 |
421 |
$2K |
| 87088 |
|
717 |
698 |
$2K |
| 82565 |
|
399 |
364 |
$2K |
| 90686 |
|
77 |
76 |
$2K |
| 86800 |
|
158 |
158 |
$2K |
| 87807 |
|
399 |
378 |
$2K |
| 73620 |
|
98 |
64 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
29 |
14 |
$2K |
| 82550 |
|
560 |
527 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
108 |
101 |
$2K |
| 99215 |
Prolong outpt/office vis |
33 |
28 |
$2K |
| 29581 |
|
361 |
110 |
$2K |
| 84100 |
|
538 |
458 |
$2K |
| 97165 |
|
26 |
24 |
$2K |
| 77080 |
|
75 |
75 |
$1K |
| 52000 |
|
37 |
24 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
446 |
444 |
$1K |
| 99152 |
|
222 |
209 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
17 |
17 |
$1K |
| 76870 |
|
46 |
43 |
$1K |
| 74022 |
|
169 |
164 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
312 |
240 |
$1K |
| 86160 |
|
60 |
55 |
$1K |
| 83615 |
|
175 |
154 |
$1K |
| 86430 |
|
173 |
172 |
$941.33 |
| 0636 |
|
226 |
222 |
$941.26 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
13 |
13 |
$934.53 |
| 70498 |
|
104 |
104 |
$914.76 |
| 87205 |
|
289 |
275 |
$803.27 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
120 |
60 |
$768.50 |
| 86431 |
|
151 |
145 |
$684.00 |
| 87522 |
Neg quan hep c or qual rna |
17 |
17 |
$662.24 |
| 86308 |
|
57 |
57 |
$659.27 |
| 70486 |
|
12 |
12 |
$653.97 |
| 83525 |
|
75 |
75 |
$631.25 |
| 86704 |
|
50 |
50 |
$615.81 |
| 73090 |
|
34 |
32 |
$602.73 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
243 |
216 |
$598.56 |
| 99001 |
|
79 |
77 |
$552.23 |
| 82747 |
|
72 |
72 |
$543.75 |
| 86481 |
|
13 |
13 |
$528.00 |
| 86235 |
|
12 |
12 |
$497.52 |
| 86705 |
|
35 |
35 |
$492.38 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$462.52 |
| 86039 |
|
39 |
39 |
$447.26 |
| 84550 |
|
98 |
93 |
$444.90 |
| 82533 |
|
27 |
25 |
$442.76 |
| 84270 |
|
26 |
26 |
$411.84 |
| 95117 |
|
298 |
154 |
$384.45 |
| 0761 |
|
13 |
12 |
$378.84 |
| 82670 |
|
15 |
15 |
$370.65 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
57 |
55 |
$286.51 |
| 71020 |
|
89 |
78 |
$274.60 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
12 |
12 |
$266.82 |
| 82805 |
|
33 |
30 |
$257.31 |
| 82378 |
|
13 |
13 |
$245.20 |
| 82105 |
|
26 |
26 |
$240.60 |
| 83001 |
|
12 |
12 |
$229.11 |
| 84425 |
|
12 |
12 |
$226.44 |
| 80047 |
|
14 |
13 |
$218.54 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
12 |
$190.00 |
| 86762 |
|
31 |
28 |
$175.45 |
| 71101 |
|
12 |
12 |
$165.39 |
| 93356 |
|
12 |
12 |
$162.72 |
| 82247 |
|
21 |
12 |
$107.40 |
| 82977 |
|
14 |
12 |
$105.84 |
| 86200 |
|
14 |
14 |
$99.40 |
| 90694 |
|
20 |
20 |
$95.18 |
| 82140 |
|
15 |
15 |
$86.74 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
121 |
119 |
$78.02 |
| 84156 |
|
28 |
27 |
$75.62 |
| 82248 |
|
13 |
12 |
$75.56 |
| 90653 |
|
18 |
18 |
$74.87 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
75 |
66 |
$64.21 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
38 |
38 |
$51.01 |
| 86677 |
|
14 |
14 |
$47.75 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
12 |
12 |
$37.01 |
| 71010 |
|
15 |
13 |
$31.27 |
| 87147 |
|
12 |
12 |
$25.21 |
| 85014 |
|
30 |
28 |
$6.66 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
12 |
$3.32 |
| 87210 |
|
54 |
51 |
$2.85 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
15 |
14 |
$1.32 |
| 0710R |
|
83 |
73 |
$0.00 |
| 1159F |
|
789 |
771 |
$0.00 |
| 1160F |
|
427 |
418 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
263 |
247 |
$0.00 |
| 97161 |
|
13 |
13 |
$0.00 |
| 0258R |
|
12 |
12 |
$0.00 |
| 3008F |
|
223 |
221 |
$0.00 |
| 0250R |
|
253 |
116 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
22 |
22 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
45 |
45 |
$0.00 |
| A9150 |
Non-prescription drugs |
13 |
13 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
16 |
13 |
$0.00 |